IDXX · News · 20260804N
Revenue Performance and Mix
IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 35 · Surprise 22 · No source text
IDEXX Laboratories reported second-quarter 2026 revenue of $1,217 million, up 10% year over year on a reported basis and 9% organically. Companion Animal Group revenue increased 9% on both reported and organic bases, while Water revenue grew 15% reported and 13% organically. Livestock, Poultry and Dairy revenue increased 11% reported and 9% organically, indicating broad-based growth across the company’s operating segments.
Key facts
- Second quarter 2026 revenues: $1,217 million, an increase of 10% as reported and 9% organic. source
- Idexx reported Q2 2026 earnings per share of $4.27 vs. Zacks Consensus estimate of $3.95 and revenues of $1.22 billion vs. $1.20 billion estimate. source
- Marketscreener reports Q2 2026 revenue: $1.22 billion, surpassing FactSet estimate of $1.20 billion. source
- Water revenue growth in Q2 2026: 15% as reported and 13% organic. source
- GuruFocus: CAG Diagnostics recurring revenue grew 10.3% organically in Q2 2026. source
- Companion Animal Group (CAG) growth in Q2 2026: 9% as reported and 9% organic. source
- LPD (Livestock, Poultry and Dairy) revenue growth in Q2 2026: 11% as reported and 9% organic. source
- Marketscreener reports Q2 2026 adjusted EPS: $4.07, exceeding the FactSet estimate of $3.94. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +9.0% | Second quarter 2026 revenues: $1,217 million, an increase of 10% as reported and 9% organic. |
| net_income | positive | realized | — | Idexx reported Q2 2026 earnings per share of $4.27 vs. Zacks Consensus estimate of $3.95 and revenues of $1.22 billion vs. $1.20 billion… |